Insmed (INSM) – Hot FDA News
-
Insmed (INSM) Phase 2 WILLOW Study of INS1007 in Patients with Non-Cystic Fibrosis Bronchiectasis Achieves Primary Endpoint
-
Insmed (INSM) Announces FDA Approval of ARIKAYCE
-
-
-
-
-
-
-
-
-
Back to INSM Stock Lookup